MSF Scientific Days Asia 2024 is a conference that presents research, innovation, and experiences from treatment and humanitarian programmes across Asia. MSF Scientific Days brings together researchers, practitioners, academics, and patient representatives with the aim to catalyse improvements in the quality of care provided to patients and populations at risk. This is a platform for experts in the humanitarian global health field to come together, collaborate, and discuss the current trends and challenges in innovation and healthcare.
The endTB project aims to find shorter, less toxic and more effective treatments for ‘multidrug-resistant TB’ (MDR-TB) through:
Covering 18 countries, the project is a partnership between Partners In Health, Médecins Sans Frontières, Interactive Research & Development and financial partners Unitaid and the Transformational Investment Capacity (TIC) of MSF. This collection contains the final and intermediate results of the studies, advocacy reports, and study presentations. For more information about the endTB project, visit https://endtb.org/.